Assessment of Global Incidence and Risk Factors for Esophageal, Gastric, and Colorectal Cancers in Adolescents and Young Adults: Insights from the 2021 Global Burden of Disease Study - Scorecard - MDSpire

Assessment of Global Incidence and Risk Factors for Esophageal, Gastric, and Colorectal Cancers in Adolescents and Young Adults: Insights from the 2021 Global Burden of Disease Study

  • By

  • Huanyu Wei

  • Lei Yuan

  • Yanxia Li

  • Yutong Xia

  • Hongli Miao

  • Xinrui Xu

  • Linfei Li

  • Lei Shen

  • Mengyao Ji

  • October 31, 2025

  • 0 min

Share

Clinical Scorecard: Assessment of Global Incidence and Risk Factors for Esophageal, Gastric, and Colorectal Cancers in Adolescents and Young Adults: Insights from the 2021 Global Burden of Disease Study

At a Glance

CategoryDetail
Condition
Key MechanismsAlcohol use, Dietary risks, Tobacco, High body mass index, High fasting plasma glucose, Low physical activity, and emerging factors.
Target Population
Care Setting

Key Highlights

  • Include specific incidence rates and trends from the GBD 2021 for AYA.

Guideline-Based Recommendations

Diagnosis

    Management

    • Implement targeted prevention and control strategies based on regional risk factors, including specific interventions for AYA.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Focus on lifestyle modifications and specific therapeutic options to mitigate risk factors.

        Clinical Best Practices

        • statistical_modeling

        Related Resources & Content

        Original Source(s)

        Assessment of Global Incidence and Risk Factors for Esophageal, Gastric, and Colorectal Cancers in Adolescents and Young Adults: Insights from the 2021 Global Burden of Disease Study

        • by Huanyu Wei, Lei Yuan, Yanxia Li, Yutong Xia, Hongli Miao, Xinrui Xu, Linfei Li, Lei Shen, Mengyao Ji

        • October 31, 2025

        Related Content

        A study on risk prediction of decline in self-care ability one month after discharge in postoperative colorectal cancer patients based on routine clinical indicators

        A CDK4/6 inhibitor-armed oncolytic adenovirus reverses T cell exhaustion through the Rb-p65-CCL5 pathway and potentiates the antitumor activity of anti-PD-1 or CAR-T therapy in colorectal cancer

        Integrated single-cell and spatial transcriptomics reveal immune landscape and NKT–Th1 signatures in colorectal cancer